Andreas Halvorsen's TXG Position Overview
Andreas Halvorsen (via Viking Global Investors Lp) currently holds 747,087 shares of 10x Genomics, Inc. (TXG) worth $67.51 M, representing 0.21% of the portfolio. First purchased in 2019-Q3, this short-term holding has been held for 3 quarters.
Based on 13F filings, Andreas Halvorsen has maintained this position in TXG for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2026, adding 747,087 shares. Largest reduction occurred in Q4 2019, reducing 71,069 shares.
Analysis based on 13F filings available since 2013 Q2
Andreas Halvorsen's 10x Genomics (TXG) Holding Value Over Time
Track share changes against reported price movement
Quarterly 10x Genomics (TXG) Trades by Andreas Halvorsen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +747,087 | New Buy | 747,087 | $90.36 |
| Q4 2019 | -71,069 | Sold Out | 0 | $0.00 |
| Q3 2019 | +71,069 | New Buy | 71,069 | $50.40 |
Andreas Halvorsen's 10x Genomics Investment FAQs
Andreas Halvorsen first purchased 10x Genomics, Inc. (TXG) in Q3 2019, acquiring 71,069 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Andreas Halvorsen has held 10x Genomics, Inc. (TXG) for 3 quarters since Q3 2019.
Andreas Halvorsen's largest addition to 10x Genomics, Inc. (TXG) was in Q3 2026, adding 747,087 shares worth $67.51 M.
According to the latest 13F filing for Q3 2026, Andreas Halvorsen's firm, Viking Global Investors Lp, owns 747,087 shares of 10x Genomics, Inc. (TXG), valued at approximately $67.51 M.
As of the Q3 2026 filing, 10x Genomics, Inc. (TXG) represents approximately 0.21% of Andreas Halvorsen's publicly disclosed stock portfolio, making it one of their key holdings.
Andreas Halvorsen's peak holding in 10x Genomics, Inc. (TXG) was 747,087 shares, as reported at the end of Q3 2026.